Low Weight Loss Response to Incretin Analogs: A Systematic Review
Pamela S Gaskin, Peter S Chami · 2026
Read Low Weight Loss Response to Incretin Analogs: A Systematic Review by Pamela S Gaskin, Peter S Chami (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655991.txt.
Description
Pamela Gaskin and Peter Chami review, in twenty twenty-six, why some people lose little weight on a new class of diabetes and obesity drugs. The drugs mimic gut hormones called incretins, named GLP-1 and GIP. They are a major advance, yet responses vary widely. The review gathers factors tied to low or no response. Higher starting weight, body mass, blood sugar, and insulin resistance all predict poorer response. Gene variants in the GLP-1 receptor gene may also play a role.
Sticking to the drug regimen strongly predicts success, with each extra month linked to more loss. Diet, activity, gut microbes, male sex, and older age also shape outcomes. The authors call for validated predictors to tailor care.
Catalog record
| CREATOR | Pamela S Gaskin, Peter S Chami |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |